| Dr Susan Chung, PHARMD | |
|
201 S Atlantic Blvd, #c, Alhambra, CA 91801-6301 | |
| (626) 617-4049 | |
| Not Available |
| Full Name | Dr Susan Chung |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 201 S Atlantic Blvd, Alhambra, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700100682 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 61338 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Susan Chung, PHARMD 201 S Atlantic Blvd Apt C, Alhambra, CA 91801-6315 Ph: (626) 617-4049 | Dr Susan Chung, PHARMD 201 S Atlantic Blvd, #c, Alhambra, CA 91801-6301 Ph: (626) 617-4049 |
News Archive
Nitric oxide gas appears to directly impact the source of the classic, disabling pain crises of sickle cell disease, Georgia Health Sciences University researchers report.
A new study suggests that young people who are diagnosed with bipolar disorder and schizophrenia may be spared the side-effects of taking medication with the right diet and exercise program.
Johnson & Johnson Medical Devices Companies announced today that DePuy Synthes is introducing SENTIO MMG, a first-of-its-kind digital mechanomyography platform designed to assess nerve status and identify and avoid peripheral nerves during spine surgery.
For the first time, a prestigious technical innovation honor from the Massachusetts Institute of Technology (MIT) will go to an expert in health measurement: Abraham Flaxman, an Assistant Professor of Global Health at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington (UW).
Repligen Corporation announced today that it has filed an Investigational New Drug Application (IND) with the Food and Drug Administration (FDA) for a Phase 1 study of RG2833, a selective histone deacetylase 3 (HDAC-3) inhibitor. This is a double-blind, single ascending dose, Phase 1 study in healthy volunteers to evaluate the pharmacokinetic and safety profile of RG2833 in up to 40 subjects.
› Verified 4 days ago
Phuong Lien Ngo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 69 E Main St, Alhambra, CA 91801 Phone: 626-300-8049 | |
Dr. Andrew Duong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 S Curtis Ave Apt E, Alhambra, CA 91801 Phone: 626-800-8883 | |
Dr. Heena R Chollera, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 209 E Commonwealth Ave Apt F, Alhambra, CA 91801 Phone: 909-802-0978 | |
Raymond T Chan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 69 E Main St, Alhambra, CA 91801 Phone: 626-300-8047 | |
Chia Fang Chang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 88 S Garfield Ave Unit 128, Alhambra, CA 91801 Phone: 240-687-2659 | |
Dru Elizabeth Lezina, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Fremont Ave, Alhambra, CA 91803 Phone: 855-885-2600 | |
Angela Hyunjung Choi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 305 N 3rd St Apt B, Alhambra, CA 91801 Phone: 626-542-5415 |